KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Finished Goods (2018 - 2025)

Historic Finished Goods for ClearPoint Neuro (CLPT) over the last 12 years, with Q3 2025 value amounting to $3.5 million.

  • ClearPoint Neuro's Finished Goods changed N/A to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $3.6 million for FY2024, which is 19327.39% up from last year.
  • As of Q3 2025, ClearPoint Neuro's Finished Goods stood at $3.5 million.
  • In the past 5 years, ClearPoint Neuro's Finished Goods registered a high of $3.6 million during Q4 2024, and its lowest value of $664000.0 during Q1 2025.
  • In the last 4 years, ClearPoint Neuro's Finished Goods had a median value of $1.6 million in 2021 and averaged $2.2 million.
  • In the last 5 years, ClearPoint Neuro's Finished Goods plummeted by 1507.03% in 2021 and then soared by 19327.39% in 2024.
  • ClearPoint Neuro's Finished Goods (Quarter) stood at $1.6 million in 2021, then dropped by 21.2% to $1.2 million in 2023, then soared by 193.27% to $3.6 million in 2024, then fell by 4.01% to $3.5 million in 2025.
  • Its Finished Goods stands at $3.5 million for Q3 2025, versus $3.4 million for Q2 2025 and $664000.0 for Q1 2025.